This site is intended for Healthcare professionals only.

Bliss GVS Pharma Q2 profit up 22 Percent to Rs 41.45 crore


Bliss GVS Pharma Q2 profit up 22 Percent to Rs 41.45 crore

NEW Delhi: Bliss GVS Pharma on has reported a 22 per cent increase in consolidated profit to Rs 41.45 crore in the second quarter ended September 30, 2018. Bliss GVS Pharma had posted a profit of Rs 33.98 crore in the same period a year ago.

Bliss GVS Pharma is an Indian pharmaceutical and company headquartered in Mumbai, India. Bliss GVS primarily develops, manufactures and markets products across various therapeutic categories including Anti-fungal, Contraceptive, Laxative, Anti-haemorrhoidal, Anti-spasmodic, Anti-malarial, Anti-biotic, Anti-microbial, Anti-inflammatory, Antipyretic, Analgesic and several others

Total income of the company increased by 4.8 per cent to Rs 253.3 crore from Rs 241.7 crore during the period under review.



Source: PTI
0 comment(s) on Bliss GVS Pharma Q2 profit up 22 Percent to Rs 41.45 crore

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted